Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.260
-0.140 (-10.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $51.77 million as of February 21, 2025. Its market cap has decreased by -15.85% in one year.
Market Cap
51.77M
Enterprise Value
36.77M
1-Year Change
-15.85%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $51.77M, a decrease of -68.21%. That is a compound annual growth rate of -26.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 51.77M | 18.82% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.25B |
| UnitedHealth Group | 462.45B |
| Johnson & Johnson | 384.35B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.70B |
| Abbott Laboratories | 230.97B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |